ProQuest Financial LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 59,639 shares at $61.65 ($3.7M) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market sale of $3.7M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.66 | 16,270 | $987K | 26.8% |
| 2 | $61.65 | 11,770 | $726K | 19.7% |
| 3 | $62.21 | 31,599 | $2.0M | 53.4% |
| Total | $61.68 avg | 59,639 | $3.7M | 100% |
| Filing → |
| EGRX | SELL | 2016-08-17 | $6.1M | — | Filing → |
| EGRX | SELL | 2016-08-17 | $1.5M | — | Filing → |
| EGRX | SELL | 2016-08-17 | $3.0M | — | Filing → |